Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Accumulated Expenses (2013 - 2025)

Updated

Altamira Therapeutics (CYTOF) posted Accumulated Expenses of $393,267 for Q4 2023, down 80.8% from $2.05 million a year earlier.

Analysis

Altamira Therapeutics (CYTOF) Accumulated Expenses (2013 - 2025) Analysis & Trends

Since Q4 2018, Altamira Therapeutics has reported Accumulated Expenses for 8 quarters.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of -21.2% (FY2018 to FY2023).
  • In prior years, Altamira Therapeutics' Accumulated Expenses was $2.05 million in FY2022 (+80.5%), $1.14 million in FY2021 (-28.3%), $1.59 million in FY2020 (+17.1%) and $1.35 million in FY2019 (+4.4%).
  • The Q4 2023 figure stands as the lowest quarterly Accumulated Expenses in data going back to Q4 2018.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 901,923.00
Dec 31, 2024 489,853.00
Jun 30, 2024 577,910.00
Dec 31, 2023 413,632.35
Jun 30, 2023 1.28 Mn
Jan 1, 2023 2.14 Mn
Dec 31, 2022 2.14 Mn
Jun 30, 2022 1.89 Mn
Dec 31, 2021 1.15 Mn
Jun 30, 2021 1.73 Mn
Dec 31, 2020 1.63 Mn
Jun 30, 2020 1.23 Mn
Dec 31, 2019 1.38 Mn
Jun 30, 2019 968,172.84
Dec 31, 2018 1.31 Mn
Sep 30, 2018 3.53 Mn
Jun 30, 2018 3.57 Mn
Mar 31, 2018 4.48 Mn
Dec 31, 2017 4.78 Mn
Sep 30, 2017 393,549.24
API Access

Altamira Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CYTOF&period=max&api_key=YOUR_API_KEY